Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00274196
Other study ID # 28-17.02.06-HMO-CTIL
Secondary ID
Status Recruiting
Phase N/A
First received January 9, 2006
Last updated November 12, 2007
Start date February 2006
Est. completion date June 2008

Study information

Verified date November 2007
Source Hadassah Medical Organization
Contact Charles Milgrom, MD
Phone 00 972 50 7874401
Email charles.milgrom@ekmd.huji.ac.il
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to measure the sensitivity and specificity of ultrasound exam of the hip in diagnosing occult hip fractures.


Description:

Introduction: Most hip fractures are diagnosed by history, physical examination and confirmed by plain radiographs. When initial X-rays are negative or equivocal, and there is a clinical suspicion of occult hip fracture, additional diagnostic tests are necessary such as MRI which is expensive and in many hospitals less available, or bone scan which needs to be delayed 48-72 hours from injury to be indicative. Ultrasound examination has been shown to be an accurate measurement to diagnose occult fractures in the ankle and is a relatively easy, available, non-expansive examination. We propose the use of bedside ultrasound examination of the hip as a screening tool for occult hip fractures.

Objective: To measure the sensitivity and specificity of ultrasound exam of the hip in diagnosing or ruling out occult hip fractures.

Materials and methods: We will include all patients 40 years and older with a painful hip after an injury, and with "normal" hip X-rays. Each patient will undergo two hip ultrasounds by two different examiners. Afterwards, the patients will undergo MRI of the hip. The MRI will serve as the gold standard for treatment decisions. The results of the ultrasound will be compared to the MRI to evaluate its sensitivity and specificity.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 2008
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Patients aged 40 years or older, with suspected hip fracture but normal plain X-rays

Exclusion Criteria:

- Patients younger than 40 years and with contra-indications for MRI scan

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
ultrasound examination
a single time 10 minutes procedure within the first week after the injury
MRI scan
a single time 30 minutes procedure, performed always after the ultrasound scan

Locations

Country Name City State
Israel Hadassah Medical Organization Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

References & Publications (1)

Lubovsky O, Liebergall M, Mattan Y, Weil Y, Mosheiff R. Early diagnosis of occult hip fractures MRI versus CT scan. Injury. 2005 Jun;36(6):788-92. Epub 2005 Apr 7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison between ultrasound exam and MRI (sensitivity and specificity) 2008
See also
  Status Clinical Trial Phase
Not yet recruiting NCT00461864 - Diagnosis of Occult Hip Fractures With Ultrasound N/A